The immune system wages an internal battle every day to protect people against a broad range of infections. However, researchers have found that the immune response can sometimes make us vulnerable to the very bacteria it is supposed to protect us from.
A study published in the journal Immunity has revealed that the immune protein interleukin-22 ( IL-22 ) actually enhances the growth of dangerous bacteria, like Salmonella, which causes food poisoning, and curbs the growth of healthy bacteria commonly found in the gut.
The findings suggest that a supposedly protective immune response actually aids the growth of a gut pathogen by suppressing the growth of its closest competitors.
To protect against disease-causing pathogens, IL-22 triggers the production of antimicrobial proteins that sequester metal ions such as iron, zinc, and manganese from microbes, starving them of these essential nutrients. But until now, it has been unclear how pathogens such as Salmonella escape IL-22's defenses.
To address this question, researchers first infected normal mice, and mice genetically engineered to lack IL-22, with Salmonella. Whereas Salmonella outcompeted the common gut bacterium Escherichia coli ( E. coli ) in normal mice, the reverse was true for mice lacking IL-22.
These findings suggest that IL-22 activity reduced the E. coli population, tipping the balance of gut microbes in favor of Salmonella.
The researchers then simultaneously infected the mice with normal Salmonella as well as mutant Salmonella strains lacking cell membrane proteins for absorbing iron and zinc from the environment. Normal Salmonella strongly outcompeted these mutant strains in normal mice, but this competitive advantage was reduced in mice lacking IL-22.
These findings suggest that Salmonella relies on alternative pathways to overcome IL-22's defenses and acquire essential metal ion nutrients.
Even though IL-22 does not protect against all pathogens, the protein still plays a crucial role in controlling the spread of some harmful microbes.
Blocking interleukin-22 during infection would be too detrimental to the host, so a more promising therapeutic strategy would be to specifically target the alternative pathways used by Salmonella and potentially other pathogens to evade interleukin-22's defenses. ( Xagena )
Source: Immunity, 2014